INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 58 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,000 | 0.0% | 2,857 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | -50.0% | 2,857 | 0.0% | 0.00% | – |
| Q3 2017 | $4,000 | -93.1% | 2,857 | -86.6% | 0.00% | – |
| Q2 2017 | $58,000 | -4.9% | 21,367 | +41.1% | 0.00% | – |
| Q1 2017 | $61,000 | +8.9% | 15,142 | +15.3% | 0.00% | – |
| Q4 2016 | $56,000 | -32.5% | 13,130 | +7.5% | 0.00% | – |
| Q3 2016 | $83,000 | +53.7% | 12,213 | +31.1% | 0.00% | – |
| Q2 2016 | $54,000 | -11.5% | 9,315 | +7.0% | 0.00% | – |
| Q1 2016 | $61,000 | -10.3% | 8,707 | -8.1% | 0.00% | – |
| Q4 2015 | $68,000 | -12.8% | 9,475 | +5.0% | 0.00% | – |
| Q3 2015 | $78,000 | -49.4% | 9,024 | -5.6% | 0.00% | – |
| Q2 2015 | $154,000 | – | 9,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|